EU CHMP Recommends TRYNGOLZA for Severe Hypertriglyceridemia
Ionis Pharmaceuticals said the EMA committee adopted a positive opinion recommending an indication extension for olezarsen as an adjunct to diet, in combination with…
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
EU CHMP recommends TRYNGOLZA approval for severe hypertriglyceridemia
The European Medicines Agency’s Committee for Medicinal Products for Human Use recommended TRYNGOLZA (olezarsen) for approval in the EU for severe hypertriglyceridemia.